New Treatment Target ID’d for Radiation-Resistant Cervical Cancer

New Treatment Target ID’d for Radiation-Resistant Cervical Cancer Understanding how cells die is key to developing new treatments for many diseases, whether the goal is to make cancer cells die or keep healthy cells alive in the face of other illnesses, such as massive infections or strokes. Two new studies

Improving Drug Options for Colorectal Cancer Patients

Improving Drug Options for Colorectal Cancer Patients Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients are not eligible for these treatments because they have cancer-promoting mutations

Antipsychotic Drugs May Increase Risk of Breast Cancer

Antipsychotic Drugs May Increase Risk of Breast Cancer Tracking medications provided to over a half million U.S. women, researchers at Washington University School of Medicine in St. Louis have found that many commonly prescribed older antipsychotic medications, and some newer ones, are associated with a significant increase in risk of

New Technique May Lead to Safer Stem Cell Transplants

New Technique May Lead to Safer Stem Cell Transplants For hard-to-treat leukemias, lymphomas and other blood cancers, stem cell transplantation is the gold standard of care. The procedure involves replacing a patient’s own blood-forming stem cells with a donor’s stem cells and, in the process, eradicating cancer cells in the

Cancer Moonshot Grant Funds Research Into Reducing Health Disparities

Cancer Moonshot Grant Funds Research Into Reducing Health Disparities Washington University School of Medicine in St. Louis has received a $17 million grant from the National Institutes of Health (NIH) to address disparities in cancer research, treatment and outcomes in underrepresented populations. The research, funded through the National Cancer Institute’s

Go to Top